In contrast, astemizole inhibited basal CYP3A4 gene expression (Fig. 7B) and blocked calcitriol-dependent CYP3A4 induction (Fig. 7C), in a similar manner as that observed for CYP24A1 in breast cancer cells. Here, CYP3A4 is linked to breast cancer.